We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUMAU
601
SUMA Acquisition Corp Units
SUMAU
$13.5M 0.02%
+1,350,000
New +$13.5M
KIM icon
602
Kimco Realty
KIM
$17.6B
$13.5M 0.02%
601,463
+90,100
+18% +$1.99M
CHRW icon
603
C.H. Robinson
CHRW
$22B
$13.5M 0.02%
81,294
+65,480
+414% +$11.7M
LATA
604
Galata Acquisition Corp II
LATA
$233M
$13.5M 0.02%
1,350,000
– –
PALOU
605
Paloma Acquisition Corp I Units
PALOU
$13.5M 0.02%
+1,350,000
New +$13.5M
DYOR
606
Insight Digital Partners II
DYOR
$13.4M 0.02%
1,350,000
– –
NVGS icon
607
Navigator Holdings
NVGS
$1.34B
$13.4M 0.02%
695,000
+403,422
+138% +$7.66M
DNTH icon
608
Dianthus Therapeutics
DNTH
$5.68B
$13.4M 0.02%
+160,000
New +$9.27M
TDWD
609
Tailwind 2.0 Acquisition Corp
TDWD
$13.4M 0.02%
1,350,000
– –
ONB icon
610
Old National Bancorp
ONB
$10.1B
$13.4M 0.02%
605,000
-50,000
-8% -$1.17M
IGAC
611
Invest Green Acquisition Corp
IGAC
$13.4M 0.02%
1,350,000
– –
BR icon
612
Broadridge
BR
$17.2B
$13.4M 0.02%
82,200
+800
+1% +$152K
J icon
613
Jacobs Solutions
J
$15.9B
$13.3M 0.02%
104,827
-3,100
-3% -$421K
TWLV
614
Twelve Seas Investment Co III
TWLV
$235M
$13.3M 0.02%
+1,350,000
New +$13.4M
IRAB
615
Iris Acquisition Corp II
IRAB
$13.3M 0.02%
+1,350,000
New +$13.3M
BRX icon
616
Brixmor Property Group
BRX
$9.95B
$13.2M 0.02%
460,000
+160,000
+53% +$4.52M
SSRM icon
617
SSR Mining
SSRM
$5.57B
$13.2M 0.02%
+450,000
New +$11.9M
PHM icon
618
Pultegroup
PHM
$24.5B
$13.2M 0.02%
112,100
-53,900
-32% -$6.9M
FRMI
619
Fermi Inc
FRMI
$4.72B
$13.1M 0.02%
2,250,000
+1,430,000
+174% +$12.5M
SABS icon
620
SAB Biotherapeutics
SABS
$268M
$13M 0.02%
+3,405,553
New +$13.6M
NMRK icon
621
Newmark Group
NMRK
$2.73B
$13M 0.02%
865,000
-400,000
-32% -$6.31M
NHI icon
622
National Health Investors
NHI
$3.9B
$12.9M 0.02%
160,000
-100,000
-38% -$8.33M
AVBH
623
Avidbank Holdings
AVBH
$349M
$12.9M 0.02%
452,035
+231,720
+105% +$6.54M
BHF icon
624
Brighthouse Financial
BHF
$3.63B
$12.9M 0.02%
215,111
+67,011
+45% +$4.18M
AVTX icon
625
Avalo Therapeutics
AVTX
$976M
$12.8M 0.02%
854,000
+304,000
+55% +$4.75M
23 24
25
26 27

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.